• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Hawkins Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    4/30/25 4:06:42 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary
    Get the next $HWKN alert in real time by email
    hwkn-20250425
    0000046250FALSE00000462502025-04-252025-04-25

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    FORM 8-K
     
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported) April 25, 2025
      
    Hawkins, Inc.
    (Exact name of registrant as specified in its charter)
     
    Minnesota 0-7647 41-0771293
    (State of Incorporation) (Commission File Number) (IRS Employer Identification No.)
    2381 Rosegate,Roseville,MN55113
    (Address of Principal Executive Offices)(Zip Code)

    Registrant’s Telephone Number, Including Area Code (612) 331-6910
      
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common Stock, par value $.01 per share
    HWKN
    The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Exchange Act (17 CFR 240.12b 2).
    Emerging growth company ¨
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨




    Item 1.01. Entry into a Material Definitive Agreement.

    On April 25, 2025, Hawkins, Inc. (the "Company") entered into a second amendment (the “Amendment”) with U.S. Bank National Association (“U.S. Bank”) as Administrative Agent, Sole Lead Arranger and Sole Book Runner, and the other lenders from time to time party thereto (collectively, the “Lenders”), which amended that certain second amended and restated credit agreement dated as of March 31, 2022 (the “Existing Credit Agreement” and as amended, restated or modified from time to time, and as modified by the Amendment, the “Credit Agreement”). The Amendment increased the revolving commitment under the Existing Credit Agreement to provide the Company with senior secured revolving credit facilities (the “Revolving Loan Facility”) totaling $400.0 million. The Revolving Loan Facility includes a $10.0 million letter of credit subfacility and $25.0 million swingline subfacility. U.S. Bank, JP Morgan Chase Bank, N.A., Wells Fargo Bank, N.A., and Associated Bank, N.A. are lenders under the Credit Agreement as of the date of the Amendment.

    The Company drew approximately $150 million of the proceeds from the Revolving Loan Facility to acquire substantially all of the assets of Surplus Management, Inc. dba WaterSurplus. The Company may use proceeds from the Revolving Loan Facility for working capital, capital expenditures, restricted payments and other acquisitions permitted under the Credit Agreement, and other general corporate purposes.

    Borrowings under the Revolving Loan Facility bear interest at a rate per annum equal to one of the following, plus, in both cases, an applicable margin based upon the Company’s leverage ratio: (a) Term SOFR, for an interest period of one, three or six months as selected by the Company, reset at the end of the selected interest period, or (b) a base rate determined by reference to the highest of (1) U. S. Bank’s prime rate, (2) the Federal Funds Effective Rate plus 0.5%, or (3) one-month Term SOFR for U.S. dollars plus 1.0%. The Term SOFR margin is between 1.0% - 1.85%, depending on the Company’s leverage ratio. The base rate margin is between 0.00% - 0.85%, depending on the Company’s leverage ratio.

    In addition to paying interest on the outstanding principal under the Revolving Loan Facility, the Company is required to pay a commitment fee on the unutilized commitments thereunder. The commitment fee is between 0.15% - 0.25%, depending on the Company’s leverage ratio.

    The Revolving Loan Facility is scheduled to mature on April 25, 2030.

    The Revolving Loan Facility is secured by substantially all of the personal property assets of the Company and its subsidiaries.

    The Credit Agreement will require the Company to maintain (a) a minimum fixed charge coverage ratio of 1.15 to 1.00 and (b) a maximum total cash flow leverage ratio of 3.5 to 1.0, subject to an election by the Company to increase the maximum total cash flow leverage ratio to 4.0 to 1.0 after certain Permitted Acquisitions subject to limitations set forth in the Credit Agreement. The Credit Agreement also contains other customary affirmative and negative covenants, including covenants that restrict the ability of the Company and its subsidiaries to incur additional indebtedness, dispose of significant assets, make certain investments, including any acquisitions other than permitted acquisitions, make certain payments, enter into sale and leaseback transactions, grant liens on its assets or rate management transactions, subject to certain limitations. The Company will be permitted to make distributions, pay dividends and repurchase shares so long as no default or event of default exists or would exist as a result thereof.

    The Credit Agreement contains customary events of default, the occurrence of which would permit the lenders to terminate their commitments and accelerate loans under the Revolving Loan Facility, including failure to make payments under the Revolving Loan Facility, failure to comply with covenants in the Credit Agreement and other loan documents, cross default to other material indebtedness of the Company or any of its subsidiaries, failure of the Company or any of its subsidiaries to pay or discharge material judgments, bankruptcy of the Company or any of its subsidiaries, and change of control of the Company.

    Each of U.S. Bank, JP Morgan, Wells Fargo and Associated Bank has performed and may continue to perform commercial banking and financial services for the Company and its subsidiaries for which they have receive and will continue to receive customary fees.

    Item 1.02. Termination of a Material Definitive Agreement.
    The disclosure under Item 1.01 of this Current Report on Form 8-K regarding the Existing Credit Agreement and its termination in connection with the Credit Agreement is incorporated herein by reference.

    Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
    The disclosure under Item 1.01 of this Current Report on Form 8-K regarding the Credit Agreement is incorporated herein by reference.





    Item 9.01. Financial Statements and Exhibits.
    (d)Exhibits.
    Exhibit No.  Description  Method of Filing
    10.1
    Third Amended and Restated Credit Agreement dated as of April 25, 2025, among Hawkins, Inc., the lenders party thereto, and U.S. Bank National Association, as an LC Issuer, Swing Line Lender and Administrative Agent.
    Filed Electronically
    104 Cover Page Interactive Data File (embedded within the inline XBRL document)Filed Electronically




    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     HAWKINS, INC.
    Date: April 30, 2025 By: /s/ Jeffrey P. Oldenkamp
      Jeffrey P. Oldenkamp
      
    Executive Vice President and Chief Financial Officer


    Get the next $HWKN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HWKN

    DatePrice TargetRatingAnalyst
    7/24/2025Mkt Perform
    Raymond James
    4/14/2025$160.00Neutral → Buy
    BWS Financial
    4/1/2025$125.00Market Outperform
    CJS Securities
    10/16/2024Buy → Neutral
    BWS Financial
    8/7/2023$62.00Neutral → Buy
    BWS Financial
    2/3/2022$44.00 → $52.00Buy
    BWS Financial
    More analyst ratings

    $HWKN
    SEC Filings

    View All

    Hawkins Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HAWKINS INC (0000046250) (Filer)

    8/8/25 7:47:05 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - HAWKINS INC (0000046250) (Filer)

    8/1/25 8:17:38 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 10-Q filed by Hawkins Inc.

    10-Q - HAWKINS INC (0000046250) (Filer)

    7/30/25 4:16:10 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hawkins, Inc. to Participate in the Seaport Research Partners' 14th Annual Summer Investor Conference

    ROSEVILLE, Minn., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that Patrick Hawkins, Chief Executive Officer, and Jeff Oldenkamp, Chief Financial Officer, will participate in Seaport Research Partners' 14th Annual Summer Investor Conference. The conference will be held virtually August 19 to August 20, 2025 and is hosted by Seaport Research Partners. It is expected to include over 500 institutional buy-side investors and feature one-on-one and small group meetings. Hawkins will participate on August 20, 2025. For more information about the conference or to schedule a meeting with Hawkins manage

    8/6/25 9:36:14 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc. Reports First Quarter Fiscal 2026 Results

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced results for the three months ended June 29, 2025, its first quarter of fiscal 2026. First Quarter Fiscal Year 2026 Highlights: Record quarterly results for revenue, gross profit, operating income, net income, diluted earnings per share ("EPS") and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("adjusted EBITDA"), a non-GAAP measure.Revenue growth of 15%, including Water Treatment segment growth of 28% over the same period of the prior year.Gross profit increase of 12% over the same period of the prior year.Diluted EPS of $1.40 per share, an increase of $0.02, or 1%. A

    7/30/25 4:10:59 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc. Increases its Quarterly Cash Dividend by 6% to $0.19 Per Share

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) --  The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on July 30, 2025, increased its quarterly cash dividend by 6% to $0.19 per share, payable August 29, 2025, to shareholders of record at the close of business on August 15, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities i

    7/30/25 4:05:00 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Schumacher Mary J. was granted 628 shares, increasing direct ownership by 2% to 26,177 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    8/1/25 4:20:37 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Spethmann Jeffrey E was granted 628 shares, increasing direct ownership by 12% to 5,911 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    8/1/25 4:20:15 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Tang Yi was granted 628 shares, increasing direct ownership by 9% to 7,891 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    8/1/25 4:19:48 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Faulconbridge James A bought $161,899 worth of shares (1,800 units at $89.94), increasing direct ownership by 4% to 47,817 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    6/14/24 4:09:43 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Faulconbridge James A bought $351,036 worth of shares (4,000 units at $87.76), increasing direct ownership by 10% to 46,017 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    6/12/24 6:02:44 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Director Faulconbridge James A bought $288,907 worth of shares (3,300 units at $87.55), increasing direct ownership by 9% to 42,017 units (SEC Form 4)

    4 - HAWKINS INC (0000046250) (Issuer)

    6/10/24 4:27:25 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Raymond James initiated coverage on Hawkins

    Raymond James initiated coverage of Hawkins with a rating of Mkt Perform

    7/24/25 7:27:35 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins upgraded by BWS Financial with a new price target

    BWS Financial upgraded Hawkins from Neutral to Buy and set a new price target of $160.00

    4/14/25 9:28:56 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    CJS Securities initiated coverage on Hawkins with a new price target

    CJS Securities initiated coverage of Hawkins with a rating of Market Outperform and set a new price target of $125.00

    4/1/25 9:13:14 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hawkins Inc.

    SC 13G/A - HAWKINS INC (0000046250) (Subject)

    10/31/24 11:54:59 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

    SC 13G/A - HAWKINS INC (0000046250) (Subject)

    2/13/24 5:06:13 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

    SC 13G/A - HAWKINS INC (0000046250) (Subject)

    2/9/24 9:59:13 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Financials

    Live finance-specific insights

    View All

    Hawkins, Inc. Reports First Quarter Fiscal 2026 Results

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced results for the three months ended June 29, 2025, its first quarter of fiscal 2026. First Quarter Fiscal Year 2026 Highlights: Record quarterly results for revenue, gross profit, operating income, net income, diluted earnings per share ("EPS") and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("adjusted EBITDA"), a non-GAAP measure.Revenue growth of 15%, including Water Treatment segment growth of 28% over the same period of the prior year.Gross profit increase of 12% over the same period of the prior year.Diluted EPS of $1.40 per share, an increase of $0.02, or 1%. A

    7/30/25 4:10:59 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc. Increases its Quarterly Cash Dividend by 6% to $0.19 Per Share

    ROSEVILLE, Minn., July 30, 2025 (GLOBE NEWSWIRE) --  The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on July 30, 2025, increased its quarterly cash dividend by 6% to $0.19 per share, payable August 29, 2025, to shareholders of record at the close of business on August 15, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities i

    7/30/25 4:05:00 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    HAWKINS, INC. TO RELEASE FIRST QUARTER FISCAL 2026 FINANCIAL RESULTS ON JULY 30, 2025

    ROSEVILLE, Minn., July 16, 2025 (GLOBE NEWSWIRE) --  Hawkins, Inc. (NASDAQ:HWKN) announced today that it expects to release its financial results for its fiscal 2026 first quarter ended June 29, 2025 after the market closes on July 30, 2025 at approximately 4:10 p.m. Eastern Time.  About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 64 facilities in 28 states and creates value for its customers through superb customer se

    7/16/25 8:45:00 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    $HWKN
    Leadership Updates

    Live Leadership Updates

    View All

    THE TRŪ® SHRIMP COMPANIES APPOINTS HAWKINS AS EXCLUSIVE U.S. DISTRIBUTOR FOR TRŪ® CHITOSAN

    BALATON, Minn., Aug. 16, 2023 /PRNewswire/ -- The trū® Shrimp Companies, Inc. ("trū Shrimp") announced today that trū Shrimp has appointed Hawkins, Inc. ("Hawkins") (NASDAQ:HWKN) as the exclusive distributor of its trū® Chitosan products into the United States' pharmaceutical and medical device industries. trū Chitosan is derived from the exoskeletons of trū Shrimp's production of consumer shrimp. Chitosan is a molecule refined from the shell of shrimp and is used for numerous pharmaceutical and medical applications. trū Shrimp is the only United States producer of chitosan that meets the strict medical specifications of the United States Pharmacopoeia – National Formulary (USP-NF) monograph

    8/16/23 9:00:00 AM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary

    Hawkins, Inc.  Announces Retirement of Director John McKeon

    Minneapolis, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced that John S. McKeon has notified us of his retirement from our Board of Directors and its committees effective as of December 31, 2020.  Mr. McKeon has been a member of the Board since 1984 and has served as Chair of the Board since 2005. “We will miss Jack on the Board and appreciate his many years of dedicated service to Hawkins,” said Patrick H. Hawkins, Chief Executive Officer and President. “Over the 36 years that Jack has served on the Board, we have seen Hawkins grow tremendously in both size and scope.  With his support and guidance, we have built a solid company that is poised for cont

    12/18/20 4:10:00 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary